logo

Sector: Pharmaceuticals & Biotechnology

|

Mid Cap

Marksans Pharma Share Price

Marksans Pharma Ltd.

197.50

-5.52(-2.72%)

Invest in MARKSANS with up to 2.22x margin.

Trade with MTF
8th May 2026 | 3:28 PM
NSE : MARKSANS
Open Free Demat Account

By signing up I certify terms, conditions & privacy policy

Marksans Pharma Performance

Price Movement

₹197.50

₹197.22

₹205.90

Today's LowToday's High

1 Year Performance

₹197.50

₹155.00

₹270.70

52 Week Low52 Week High

Markets Today

High₹205.90
Low₹197.22
Open at₹204.00
Prev Close₹203.02
Volumes15.64 L
Avg Price₹200.59
Lower Circuit₹162.42
Upper Circuit₹243.62

Historical Performance

3M High₹207.00
3M Low₹155.00
1 Yr High₹270.70
1 Yr Low₹155.00
3 Yr High₹358.70
3 Yr Low₹70.55
5 Yr High₹358.70
5 Yr Low₹38.60

Marksans Pharma Fundamentals

Market Cap
Above industry Median
8,961.80 Cr.
PE Ratio (TTM)
Above industry Median
24.90
Dividend Yield
Below industry Median
0.40
Net Profit TTM
2% decr over last year
360.32
Net Profit Growth
2% decr over last year
360.32
PEG Ratio
Negative PEG TTM
-11.40
ROE
1.5% incr over last year
15.42
Operating Revenue TTM
2,803.28
Operating Revenue Growth
13.3% incr over last year
Book Value
Above industry Median
3.20
MFI
MFI strongly Overbought
86.24
RSI
RSI is mid-range
68.17
EPS (TTM)
8.40
Debt to Equity
0.01
Face Value
1
Operating Profit Margin Qtr.
19.63
Operating Profit Qtr.
160.74
Net Profit Qtr.
113.20
Operating Revenue Qtr.
754.43
PB Ratio
3.20

Marksans Pharma Financials

*All values are in Rs. Cr
Loading chart...
Indicator
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Total Revenue339.73320.44319.73299.36311.86
Operating Expense264.28248.37249.68248.78251.92
Operating Profit75.4472.0870.0550.5759.94
Depreciation8.838.468.198.187.42
Interest0.360.320.300.310.30
Tax21.2021.6915.5212.3119.26
Net Profit60.9199.8148.0637.5955.46

Marksans Pharma Technicals

Marksans Pharma Ltd. EMA & SMA

197.50

-5.52 (-2.72%)

Bullish Moving Average

16

Bearish Moving Average

0

Day EMA5 ₹194.4
Day EMA10 ₹190.3
Day EMA12 ₹189
Day EMA20 ₹185.1
Day EMA26 ₹183
Day EMA50 ₹179.3
Day EMA100 ₹179.7
Day EMA200 ₹188

Marksans Pharma Support and Resistance

Resistance

First Resistance₹205.45
Second Resistance₹207.87
Third Resistance₹211.75

Support

First Support₹199.15
Second Support₹195.27
Third Support₹192.85

Technical Indicators

Day RSI68.17
Day MFI86.24
Day ADX18.83
Day Commodity Channel Index175.40
William-12.52
Day MACD6.03
Day MACD Signal Line4.58
Day ATR7.97
Day ROC12511.50
Day ROC2122.10

Marksans Pharma Shareholding Pattern

Held ByDec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Promoter43.943.943.943.943.943.9
FII2222.219.916.98.116.8
DII4.24.55.55.35.96.5
Public29.929.430.733.942.132.8

Marksans Pharma Delivery And Volume

PeriodCombined Delivery VolumeNSE+BSE Traded Volume AvgDaily Avg Delivery Volume %
Day10.23 L28.24 L36.21%
Week10.92 L34.44 L31.71%
1 Month5.36 L14.73 L36.37%
6 Month4.02 L9.26 L43.41%

Marksans Pharma SWOT Analysis

Strengths20
Weakness6
Opportunity5
Threats0

Benjamin Graham Value Screen

Companies with 10% increase in share price over three months, with rising net profit growth

Strong Momentum: Price above short, medium and long term moving averages

Mid-range Performer (DVM)

Relative Outperformance versus Industry over 1 Month

PEG lower than Industry PEG

Stocks gaining versus previous close, open price and RSI

High Momentum Scores (Technical Scores greater than 50)

Relative Outperformance versus Industry over 1 Week

Relative Outperformance versus Industry over 1 Month

Overbought by Money Flow Index (MFI)

Growth in Net Profit with increasing Profit Margin (QoQ)

Companies with Low Debt

Increasing Revenue every quarter for the past 2 quarters

Increasing profits every quarter for the past 2 quarters

Annual Net Profits improving for last 2 years

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

RSI indicating price strength

Stocks Outperforming their Industry Price Change in the Quarter

Marksans Pharma Corporate Action

Ex-Date
Dividend Amount
Dividend Type
Record Date
Instrument Type
01 Aug, 20250.8FINAL01 Aug, 2025Equity Share
17 Sep, 20240.6FINAL17 Sep, 2024Equity Share
07 Jun, 20230.5FINAL07 Jun, 2023Equity Share
19 Aug, 20220.25FINALEquity Share
15 Sep, 20210.25FINALEquity Share
22 Sep, 20200.1FINALEquity Share
19 Sep, 20190.05FINALEquity Share
19 Sep, 20180.05FINALEquity Share
19 Sep, 20170.05FINALEquity Share
22 Sep, 20160.12FINALEquity Share

Marksans Pharma Stock Comparison

Financials
Price (₹)₹1,685.20₹660₹950₹4,775₹558.05₹491
% Change-3.31%-1.83%-0.14%0.30%1.83%0.13%
Revenue TTM (₹ Cr)--₹1,598.19₹935₹4,256.70₹1,053.10
Net Profit TTM (₹ Cr)--₹206.20₹257.90₹318.19₹293.57
PE TTM--76.5042.6027.6029.00
1 Year Return61.2310.9697.07-3.768.77-33.56
ROCE30.2434.7834.76-11.2752.32

FAQ's on MARKSANS

Desktop BannerMobile Banner
Invest Anytime, Anywhere
Play StoreApp Store
Open Free Demat Account Online

By signing up I certify terms, conditions & privacy policy